PROCEPT BioRobotics Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
PRCT Nasdaq 3840 www.procept-biorobotics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PROCEPT BioRobotics Corporation

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026 - Oct 12th, 2026 2:05 pm
PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change - Oct 8th, 2026 9:14 am
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls - Oct 7th, 2026 8:00 am
Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)? - Oct 6th, 2026 11:07 am
THINK Surgical Appoints Rick McDowell as Vice President, Sales - Sep 22nd, 2026 8:46 am
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? - Aug 18th, 2026 4:31 pm
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 - Aug 17th, 2026 6:00 am
PROCEPT BioRobotics (PRCT) Q2 2026 Earnings Call Transcript - Aug 11th, 2026 5:30 pm
PROCEPT BioRobotics (PRCT) Stock Sees Fair Value Falls As Analysts Cut Growth Views - Aug 8th, 2026 10:12 am
PROCEPT BioRobotics Corporation Q2 2026 Earnings Call Summary - Aug 5th, 2026 6:30 am
PROCEPT BioRobotics Corp (PRCT) (Q2 2026) Earnings Call Highlights: Strong HYDROS Demand Drives ... - Aug 4th, 2026 11:04 pm
PROCEPT BioRobotics Q2 Earnings Call Highlights - Aug 4th, 2026 8:03 pm
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates - Aug 4th, 2026 5:00 pm
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results - Aug 4th, 2026 2:05 pm
The Bull Case For PROCEPT BioRobotics (PRCT) Could Change Following Handpiece Discounting Lawsuits Learn Why - Jul 29th, 2026 9:17 pm
Processa Pharmaceuticals Acquires Vidya Therapeutics and Secures $200 Million Financing to Advance BTK Inhibitor Pipeline - Jul 29th, 2026 8:33 am
PROCEPT BioRobotics (PRCT) Could Be 30% Undervalued Following Class Action Scrutiny - Jul 28th, 2026 3:14 pm